The costs of nonbeneficial treatment in the intensive care setting.
暂无分享,去创建一个
Jeffrey Blustein | Felicia Cohn | T. Gilmer | R. Cranford | L. Schneiderman | Todd Gilmer | Lawrence J Schneiderman | Holly Teetzel | Kathleen Briggs | Ronald Cranford | Daniel Dugan | Glen Kamatsu | Ernlé Young | D. Dugan | H. Teetzel | J. Blustein | F. Cohn | E. Young | Kathleen B. Briggs | Glen Kamatsu
[1] D C Angus,et al. Economics of end-of-life care in the intensive care unit , 2001, Critical care medicine.
[2] J. Newhouse,et al. Providing care at the end of life: do Medicare rules impede good care? , 2001, Health affairs.
[3] E. Emanuel,et al. The economics of dying. The illusion of cost savings at the end of life. , 1994, The New England journal of medicine.
[4] H. White. A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity , 1980 .
[5] M. Ribbe,et al. Health Care for Older Persons, A country Profile: The Netherlands , 2000, Journal of the American Geriatrics Society.
[6] H. Arkes,et al. Rethinking Fundamental Assumptions: SUPPORT'S Implications for Future Reform , 2000, Journal of the American Geriatrics Society.
[7] V W Berger,et al. Pros and cons of permutation tests in clinical trials. , 2000, Statistics in medicine.
[8] M. Siegler,et al. What Are the Goals of Ethics Consultation? A Consensus Statement , 1996, The Journal of Clinical Ethics.
[9] S. Schroeder. The Legacy of SUPPORT , 1999, Annals of Internal Medicine.
[10] T. Gilmer,et al. Impact of ethics consultations in the intensive care setting: A randomized, controlled trial , 2000, Critical care medicine.
[11] T. Bleck,et al. Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: One-year outcomes and lessons learned* , 2003, Critical care medicine.
[12] William A. Knaus,et al. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. , 1995, JAMA.
[13] S. Bratton,et al. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit , 2002, Critical care medicine.
[14] T. Gilmer,et al. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. , 2003, JAMA.
[15] T. Noseworthy,et al. National estimates of intensive care utilization and costs: Canada and the United States. , 1990, Critical care medicine.
[16] R. Tibshirani,et al. An introduction to the bootstrap , 1993 .
[17] S. Pantilat,et al. Prevalence and structure of palliative care services in California hospitals. , 2003, Archives of internal medicine.
[18] A. Jonsen,et al. Medical futility: its meaning and ethical implications. , 1990, Annals of internal medicine.